Which Stock Will Triumph in Med Tech's Fiercest Rivalry?

Edwards and Medtronic square off in the heated transcatheter aortic heart valve market on the heels of a pair of study results.

Apr 3, 2014 at 9:30AM

Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) have taken drastically different paths over the recent past. While Medtronic's thrived behind its diversity and strong sales growth in up-and-coming medical device technologies, Edwards' stock has floundered by more than 10% over the past year behind lower-than-expected sales growth from its flagship Sapien heart valve. While Edwards has long held sole U.S. approval in the transcatheter aortic heart valve market with the Sapien, Medtronic broke through to break that dominance down recently with the Food and Drug Administration's approval of its CoreValve device in January.

That's scary news for Edwards and its investors, who now have to face off with growing competition on the homefront as well as overseas in Europe, where Medtronic and other heart valve makers have infringed on Edwards' territory. But can Edwards rebound to entrench its dominance in this growing market? A pair of clinical studies recently offers promise for the heart valve market for medical device makers -- and for Edwards, in particular.

What's in store for this underperforming med tech stock? Find out in the video below as Motley Fool contributor Dan Carroll takes you through Edwards Lifesciences' latest hope in its struggle against Medtronic and other rivals in the heart valve market, and shows you which stock is poised to make the most of this growing niche.

The simplest key to your long-term financial success
Don't let Edwards' stock drop over the past year dissuade your investing optimism. One of the dirty secrets that few finance professionals will openly admit is the fact that dividend stocks as a group handily outperform their non-dividend-paying brethren. The reasons for this are too numerous to list here, but you can rest assured that it's true. However, knowing this is only half the battle. The other half is identifying which dividend stocks in particular are the best. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.

Dan Carroll has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information